Cargando…
Mice deficient in the mitochondrial branched-chain aminotransferase (BCATm) respond with delayed tumour growth to a challenge with EL-4 lymphoma
BACKGROUND: The mitochondrial branched-chain aminotransferase (BCATm) is a recently discovered cancer marker with a poorly defined role in tumour progression. METHODS: To understand how a loss of function of BCATm affects cancer, the global knockout mouse BCATmKO was challenged with EL-4 lymphoma un...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203766/ https://www.ncbi.nlm.nih.gov/pubmed/30318512 http://dx.doi.org/10.1038/s41416-018-0283-7 |
_version_ | 1783365928785805312 |
---|---|
author | Ananieva, Elitsa A. Bostic, Joshua N. Torres, Ashley A. Glanz, Hannah R. McNitt, Sean M. Brenner, Michelle K. Boyer, Michael P. Addington, Adele K. Hutson, Susan M. |
author_facet | Ananieva, Elitsa A. Bostic, Joshua N. Torres, Ashley A. Glanz, Hannah R. McNitt, Sean M. Brenner, Michelle K. Boyer, Michael P. Addington, Adele K. Hutson, Susan M. |
author_sort | Ananieva, Elitsa A. |
collection | PubMed |
description | BACKGROUND: The mitochondrial branched-chain aminotransferase (BCATm) is a recently discovered cancer marker with a poorly defined role in tumour progression. METHODS: To understand how a loss of function of BCATm affects cancer, the global knockout mouse BCATmKO was challenged with EL-4 lymphoma under different diet compositions with varying amounts of branched-chain amino acids (BCAAs). Next, the growth and metabolism of EL-4 cells were studied in the presence of different leucine concentrations in the growth medium. RESULTS: BCATmKO mice experienced delayed tumour growth when fed standard rodent chow or a normal BCAA diet. Tumour suppression correlated with 37.6- and 18.9-fold increases in plasma and tumour BCAAs, 37.5% and 30.4% decreases in tumour glutamine and alanine, and a 3.5-fold increase in the phosphorylation of tumour AMPK in BCATmKO mice on standard rodent chow. Similar results were obtained with a normal but not with a choice BCAA diet. CONCLUSIONS: Global deletion of BCATm caused a dramatic build-up of BCAAs, which could not be utilised for energy or amino acid synthesis, ultimately delaying the growth of lymphoma tumours. Furthermore, physiological, but not high, leucine concentrations promoted the growth of EL-4 cells. BCATm and BCAA metabolism were identified as attractive targets for anti-lymphoma therapy. |
format | Online Article Text |
id | pubmed-6203766 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-62037662019-10-15 Mice deficient in the mitochondrial branched-chain aminotransferase (BCATm) respond with delayed tumour growth to a challenge with EL-4 lymphoma Ananieva, Elitsa A. Bostic, Joshua N. Torres, Ashley A. Glanz, Hannah R. McNitt, Sean M. Brenner, Michelle K. Boyer, Michael P. Addington, Adele K. Hutson, Susan M. Br J Cancer Article BACKGROUND: The mitochondrial branched-chain aminotransferase (BCATm) is a recently discovered cancer marker with a poorly defined role in tumour progression. METHODS: To understand how a loss of function of BCATm affects cancer, the global knockout mouse BCATmKO was challenged with EL-4 lymphoma under different diet compositions with varying amounts of branched-chain amino acids (BCAAs). Next, the growth and metabolism of EL-4 cells were studied in the presence of different leucine concentrations in the growth medium. RESULTS: BCATmKO mice experienced delayed tumour growth when fed standard rodent chow or a normal BCAA diet. Tumour suppression correlated with 37.6- and 18.9-fold increases in plasma and tumour BCAAs, 37.5% and 30.4% decreases in tumour glutamine and alanine, and a 3.5-fold increase in the phosphorylation of tumour AMPK in BCATmKO mice on standard rodent chow. Similar results were obtained with a normal but not with a choice BCAA diet. CONCLUSIONS: Global deletion of BCATm caused a dramatic build-up of BCAAs, which could not be utilised for energy or amino acid synthesis, ultimately delaying the growth of lymphoma tumours. Furthermore, physiological, but not high, leucine concentrations promoted the growth of EL-4 cells. BCATm and BCAA metabolism were identified as attractive targets for anti-lymphoma therapy. Nature Publishing Group UK 2018-10-15 2018-10-16 /pmc/articles/PMC6203766/ /pubmed/30318512 http://dx.doi.org/10.1038/s41416-018-0283-7 Text en © Cancer Research UK 2018 https://creativecommons.org/licenses/by/4.0/Note: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0). |
spellingShingle | Article Ananieva, Elitsa A. Bostic, Joshua N. Torres, Ashley A. Glanz, Hannah R. McNitt, Sean M. Brenner, Michelle K. Boyer, Michael P. Addington, Adele K. Hutson, Susan M. Mice deficient in the mitochondrial branched-chain aminotransferase (BCATm) respond with delayed tumour growth to a challenge with EL-4 lymphoma |
title | Mice deficient in the mitochondrial branched-chain aminotransferase (BCATm) respond with delayed tumour growth to a challenge with EL-4 lymphoma |
title_full | Mice deficient in the mitochondrial branched-chain aminotransferase (BCATm) respond with delayed tumour growth to a challenge with EL-4 lymphoma |
title_fullStr | Mice deficient in the mitochondrial branched-chain aminotransferase (BCATm) respond with delayed tumour growth to a challenge with EL-4 lymphoma |
title_full_unstemmed | Mice deficient in the mitochondrial branched-chain aminotransferase (BCATm) respond with delayed tumour growth to a challenge with EL-4 lymphoma |
title_short | Mice deficient in the mitochondrial branched-chain aminotransferase (BCATm) respond with delayed tumour growth to a challenge with EL-4 lymphoma |
title_sort | mice deficient in the mitochondrial branched-chain aminotransferase (bcatm) respond with delayed tumour growth to a challenge with el-4 lymphoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203766/ https://www.ncbi.nlm.nih.gov/pubmed/30318512 http://dx.doi.org/10.1038/s41416-018-0283-7 |
work_keys_str_mv | AT ananievaelitsaa micedeficientinthemitochondrialbranchedchainaminotransferasebcatmrespondwithdelayedtumourgrowthtoachallengewithel4lymphoma AT bosticjoshuan micedeficientinthemitochondrialbranchedchainaminotransferasebcatmrespondwithdelayedtumourgrowthtoachallengewithel4lymphoma AT torresashleya micedeficientinthemitochondrialbranchedchainaminotransferasebcatmrespondwithdelayedtumourgrowthtoachallengewithel4lymphoma AT glanzhannahr micedeficientinthemitochondrialbranchedchainaminotransferasebcatmrespondwithdelayedtumourgrowthtoachallengewithel4lymphoma AT mcnittseanm micedeficientinthemitochondrialbranchedchainaminotransferasebcatmrespondwithdelayedtumourgrowthtoachallengewithel4lymphoma AT brennermichellek micedeficientinthemitochondrialbranchedchainaminotransferasebcatmrespondwithdelayedtumourgrowthtoachallengewithel4lymphoma AT boyermichaelp micedeficientinthemitochondrialbranchedchainaminotransferasebcatmrespondwithdelayedtumourgrowthtoachallengewithel4lymphoma AT addingtonadelek micedeficientinthemitochondrialbranchedchainaminotransferasebcatmrespondwithdelayedtumourgrowthtoachallengewithel4lymphoma AT hutsonsusanm micedeficientinthemitochondrialbranchedchainaminotransferasebcatmrespondwithdelayedtumourgrowthtoachallengewithel4lymphoma |